https://www.selleckchem.com/products/10058-f4.html
Cyclophosphamide (CP)-induced lung toxicity is a remaining obstacle against the beneficial use of this chemotherapeutic agent. More considerations were given to the role of Alogliptin (ALO) in ameliorating CP-induced toxicities in many tissues. We designed this study to clarify the protective potential of ALO against CP-induced lung toxicity in rats. ALO was administered for 7 days. Single-dose CP was injected on the 2nd day (200 mg/kg i.p.) to induce lung toxicity. Rats were divided into four groups control, ALO-treated, CP-treated an
Like
Comment
Share
